Discover ASSET Loan Management tool - Top alternatives, customer information and buyer intent data. Compare ASSET with the biggest competitors in the Loan Management market like Bectran Nomis etc.
Find customers using ASSET. Additionally, find customers with upcoming contract renewals and propensity to buy similar technologies.
Discover competitors of ASSET to find prospects, market share, technology movements, buying patterns and compare technologies against each other.
Look up customers for ASSET using Employee Count. Know their target company size to create targeted sales and marketing campaigns.
Understand primary industries that ASSET sells to and new
industries they are tapping into
Find customers using ASSET by region, country, state,
city and pin codes.
ASSET’s Top competitors in the loan-management category are Bectran Nomis Maxwell Financial Labs. You can view a full list of ASSET competitors here. Slintel uses advanced data mining and AI algorithms to track customers and competitors of ASSET and 40,000 other technologies on the internet.You can also compare ASSET and its feature with top competitors here : ASSET vs Bectran ASSET vs Nomis ASSET vs Maxwell Financial Labs .
Majority of ASSET’s customers for the loan-management category fall in the company size of 1-10 employees (1 companies) . You can view a distribution chart of ASSET customers by company size here.
ASSET has market share of 0.09% in loan-management market. ASSET competes with 66 competitor tools in loan-management category. Top alternatives for ASSET loan-management tool are Bectran with 18.91% Nomis with 7.65% Maxwell Financial Labs with 6.51% market share.
Top industries that use ASSET for loan-management are Advertising (1) Branding (1) Content Strategy (1) .
Around the world in 2021, over 1 companies have started using ASSET as loan-management tool. Companies using ASSET for loan-management are majorly from Canada with 1 customers. 100.00% of ASSET customers are from the Canada. Other top countries using ASSET are with customers respectively.